Search

Author/Creator Anai, Motonobu

1. Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase‐4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24‐week, open‐label, controlled trial (STOP‐OB). Issue 9 (7th May 2020)

Authors:
Kitazawa, Toru; Seino, Hiroaki; Ohashi, Hiroshi; Inazawa, Takeshi; Inoue, Masahiro; Ai, Masumi; Fujishiro, Midori; Kuroda, Hisamoto; Yamada, Masayo; Anai, Motonobu; Ishihara, Hisamitsu
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 9(2020)
Page Start:
1659
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Synergistic association of the copper/zinc ratio under inflammatory conditions with diabetic kidney disease in patients with type 2 diabetes: The Asahi Diabetes Complications Study. Issue 2 (7th October 2021)

Authors:
Takao, Toshiko; Yanagisawa, Hiroyuki; Suka, Machi; Yoshida, Yoko; Onishi, Yukiko; Tahara, Tazu; Kikuchi, Takako; Kushiyama, Akifumi; Anai, Motonobu; Takahashi, Kazuyuki; Wakabayashi Sugawa, Sayaka; Yamazaki, Hiroki; Kawazu, Shoji; Iwamoto, Yasuhiko; Noda, Mitsuhiko; Kasuga, Masato
Journal:
Journal of diabetes investigation
Issue:
Volume 13:Issue 2(2022)
Page Start:
299
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗